<DOC>
	<DOC>NCT02981524</DOC>
	<brief_summary>This study will be looking at the objective response rate (ORR) as measured by RECIST in in patients with mismatch repair-proficient (MMR-p), advanced colorectal cancer that treated with CY/GVAX in combination with Pembrolizumab.</brief_summary>
	<brief_title>Phase 2 Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Pembrolizumab</mesh_term>
	<criteria>1. Documented mismatch repairproficient cancer of colorectum, who have received at least two prior lines of therapy for metastatic disease 2. ECOG Performance Status of 0 to 1 3. Adequate organ function as defined by studyspecified laboratory tests 4. Must use acceptable form of birth control through the study and for 120 days after final dose of study drug 5. Signed informed consent form 6. Willing and able to comply with study procedures 1. Currently have or have history of certain studyspecified heart, liver, kidney, lung, neurological, immune or other medical conditions 2. Systemically active steroid use 3. Another investigational product within 28 days prior to receiving study drug 4. Major surgery or significant traumatic injury (or unhealed surgical wounds) occurring within 28 days prior to receiving study drug 5. Chemotherapy, radiation, hormonal, or biological cancer therapy within 28 days prior to receiving study drug 6. Pregnant or lactating 7. Unwilling or unable to comply with study procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Gastrointestinal Neoplasms</keyword>
	<keyword>Digestive System Neoplasms</keyword>
	<keyword>Neoplasms by Site</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Rectal Diseases</keyword>
	<keyword>Colonic Diseases</keyword>
</DOC>